Press release
Japan PSMA PET Imaging Market is expected to reach US$ 50 million by 2032 | Major Companies - Novartis Pharmaceuticals Corporation, Lantheus Company, RadioMedix, Clarity Pharmaceuticals
Market Size and Growth:The Global PSMA PET Imaging Market size reached US$ 1.5 billion in 2022 and is expected to reach US$ 2.0 billion by 2030, growing with a CAGR of 3% during the forecast period 2024-2031.
The PSMA PET Imaging Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/psma-pet-imaging-market?sz
The PSMA PET Imaging Market refers to the global industry focused on developing, producing, and commercializing prostate-specific membrane antigen-based PET imaging agents and technologies used primarily for prostate cancer detection, staging, and recurrence monitoring. It includes radiotracers, imaging systems, and related diagnostic services supporting precision oncology and personalized treatment planning.
Recent Key Developments of Japan:
✅ October 2025: Curium Group, PeptiDream, and PDRadiopharma enrolled the first patient in a registrational Phase 2 clinical trial for 64Cu-PSMA-I&T, evaluating its sensitivity, specificity, and safety in high-risk prostate cancer patients prior to prostatectomy.
October 2025: Emphasis on Technological Advancements:
✅ Japan leads in PSMA PET innovations, including next-generation radiotracers for better targeting, hybrid imaging systems for higher resolution, and AI tools to enhance accuracy and reduce scan times. These align with clinical research and regulatory support for early adoption
Recent Key Developments of Europe:
✅ November 2025: European Society of Urogenital Radiology review detailed PSMA PET/CT merits for advanced prostate cancer staging, emphasizing its superiority over traditional methods despite limitations in low-PSMA expression cases.
✅ October 2025: BiPASS trial launched to assess combined MRI and 68Ga-PSMA-11 PET for improved prostate cancer detection, aiming to enhance sensitivity/specificity and minimize unnecessary biopsies.
✅ October 2025: Study validated a PSMA PET molecule for earlier detection of prostate cancer recurrence by effectively binding to cancer cells, supporting better monitoring in European clinical settings.
List of the Key Players in the PSMA PET Imaging Market:
Novartis Pharmaceuticals Corporation
Lantheus company
RadioMedix
Clarity Pharmaceuticals
Blue Earth Diagnostics, Inc.
Siemens Medical Solutions USA, Inc.
Eckert & Ziegler
Telix Pharmaceuticals
Canon Medical Systems, USA
Jubilant Draximage Radiopharmacies, Inc.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/psma-pet-imaging-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the PSMA PET Imaging Market:
By Technology: Gallium-68 (Ga-68) PSMA PET Imaging, Fluorine-18 (F-18) PSMA PET Imaging.
By End-User: Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Research and Academic Centers.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=psma-pet-imaging-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, PSMA PET Imaging market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global PSMA PET Imaging Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global PSMA PET Imaging market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the PSMA PET Imaging Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the PSMA PET Imaging Market in 2025?
◆ What is the projected growth rate of the PSMA PET Imaging Market through 2033?
◆ Who are the key players in the PSMA PET Imaging Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Japan PSMA PET Imaging Market is expected to reach US$ 50 million by 2032 | Major Companies - Novartis Pharmaceuticals Corporation, Lantheus Company, RadioMedix, Clarity Pharmaceuticals here
News-ID: 4331486 • Views: …
More Releases from DataM Intelligence 4Market Research
Japan Phytogenic Feed Additives Market is expected to reach USD 42.1 billion by …
Market Size and Growth:
The Global Phytogenic Feed Additives Market size reached USD 869.2 million in 2022 and is expected to reach USD 1585.1 million by 2030, growing with a CAGR of 7.8% during the forecast period 2024-2031.
The Phytogenic Feed Additives Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
Japan Polymer Coated Urea Market is expected to reach USD 2.0 billion by 2033 | …
Market Size and Growth:
The Global Polymer Coated Urea Market size reached USD 1035.1 million in 2022 and is expected to reach USD 1662.2 million by 2030, growing with a CAGR of 6.1% during the forecast period 2024-2031.
The Polymer Coated Urea Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
Japan Patient Engagement Solutions Market is expected to reach US$ 16,167.26 bil …
Market Size and Growth:
The Japan Patient Engagement Solutions Market size reached US$ 2731.41 billion in 2024 and is expected to reach US$ 16,167.26 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.
The Japan Patient Engagement Solutions Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses…
Japan Cardiac Surgery Instruments Market is expected to reach US$ 166.65 million …
Market Size and Growth:
The Japan Cardiac Surgery Instruments Market size reached US$ 82.68 million in 2024 and is expected to reach US$ 166.65 million by 2033, growing at a CAGR of 8.1 % during the forecast period 2025-2033.
The Japan Cardiac Surgery Instruments Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers…
More Releases for PSMA
PSMA-Targeted Radioligand Therapies Market Size, Clinical Trials, Product Pipeli …
PSMA-Targeted Radioligand Therapies Market Size is estimated to be $470 million in 2024 and is expected to grow at an average yearly rate of around 6% during the timeframe (2025-2032).
What is PSMA-Targeted Radioligand Therapies and what are the growth drivers of PSMA-Targeted Radioligand Therapies Market?
Prostate-Specific Membrane Antigen (PSMA)-targeted radioligand therapies are an advanced form of targeted cancer treatment designed specifically for prostate cancer. PSMA is a protein…
PSMA Antibody Market is estimated to expand at USD 3.5 billion by 2034, driven b …
" The PSMA (Prostate-Specific Membrane Antigen) antibody market is poised for significant growth, with a current market value estimated at approximately $1.2 billion in 2024. By 2034, this market is projected to reach around $3.5 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of approximately 11.4% during the forecast period of 2025-2034. "
Exactitude Consultancy., Ltd. released a research report titled "PSMA Antibody Market". This report covers the global PSMA…
Psma Pet Imaging Market: Expected Positive Growth Trends Through 2024-2031
The Psma Pet Imaging Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Get a Free Sample PDF - https://datamintelligence.com/download-sample/psma-pet-imaging-market
What is the projected growth rate (CAGR) of the Global Psma Pet…
PSMA PET Imaging Market Size, Trends, Share & Forecast 2023-2030 | Industry Outl …
PSMA PET Imaging Market: Significant Growth Driven by Rising Cancer Detection Rates
The global PSMA PET imaging market is expected to witness significant growth in the coming years. This growth can be attributed to several factors, including:
Increasing adoption of PSMA PET for prostate cancer detection: Prostate cancer is the fourth most commonly diagnosed cancer globally. PSMA PET offers a more precise and sensitive technique for detecting prostate cancer compared to…
PSMA-PET Imaging Market : Long-Term Value & Growth Seen Ahead| GE Healthcare, En …
The Latest research study released by HTF MI "Global PSMA-PET Imaging Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major Companies covered in this Research are GE…
177-LUTETIUM-PSMA-617 Market 2020 Analysis by Expert to 2030
177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast 2030
The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of 177-LUTETIUM-PSMA-617 Market on the basis of stating current situation of the industry in 2020.
This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life…
